Lifecare ASA

Share Issue/Capital Change • Jun 6, 2025

Lifecare ASA: Notification of trade - exercise of warrants

Lifecare ASA: Notification of trade - exercise of warrants

Reference is made to the stock exchange announcement by Lifecare ASA (the

"Company") dated 2 June 2025 regarding the commencement of the exercise period

for 4,193,806 warrants (the "Warrants") issued in connection with the

partially underwritten rights issue of new shares in the Company completed in

June 2024 (the "Rights Issue").

Each Warrant gives the holder a right to subscribe for one new share in the

Company at an exercise price per share of NOK 5.31681. The Warrants are listed

and tradable on Euronext Oslo Stock Exchange under the ticker code "LIFES".

Warrants that are not exercised to subscribe for new shares before the end of

the Exercise Period at 16:30 hours (CEST) on 13 June 2025 or sold before 16:30

hours (CEST) today 6 June 2025 will have no value and will lapse without

compensation to the holder. Holders of Warrants who do not exercise their

Warrants within the Exercise Period may experience a dilution of their

shareholding in the Company.

The Company has been informed that the largest shareholder of Lifecare ASA,

Lacal AS, has exercised 253,847 Warrants, for the allocation of 253,847 New

Shares in the Company at a price per New Share of NOK 5.31681.

Subject to timely payment of the aggregate exercise amount for the new shares

on 19 June 2025, the Company expects that the share capital increase

pertaining to the issuance of the new shares will be registered with the

Norwegian Register of Business Enterprises on or about 24 June 2025 and that

shares will be delivered to the VPS accounts of the subscribers to whom they

are allocated on or about 25 June 2025.

The shares received upon exercise of Warrants will be listed on Euronext Oslo

Børs under ISIN NO0013355859 and ticker code "LIFE". The shares will be listed

as soon as the new shares are fully paid, the share capital increase

pertaining to the issuance of the new shares has been registered in the

Norwegian Register of Business Enterprises, and the new shares have been

issued in the VPS.

The shares received upon exercise of Warrants may not be transferred or traded

before (i) the new shares have been fully paid, (ii) the share capital

increase pertaining to the issuance of the new shares has been registered with

the Norwegian Register of Business Enterprises, and (iii) the new shares have

been issued in the VPS.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring ("CGM") systems to market.

Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor

technology is suitable for identifying and monitoring the occurrence of a wide

range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42